CD4 and diabetes mellitus: Global gene expression profiling was also performed on un-activated peripheral lymphoid tissues as well as activated CD4+ T-cells derived from NOD mice and diabetes resistant NOD congenic strains, as well as prediabetic NOD mice immunized with glutamic acid decarboxylase peptide to protect against diabetes [15]–[20].